Market Place
Sourcing Support
Caplin gets USFDA approval for Haloperidol Decanoate Injection
15 May 2025 //
INDPHARMAPOST
Lawsuit accuses Gilead of propping up cost of lifesaving HIV treatments
14 May 2019 //
CNBC
Lupin-Natco get USFDA nod to market generic hypertension drug
30 Apr 2019 //
MONEYCONTROL
Novartis plots new course for Sandoz
01 Feb 2019 //
BIOCENTURY
MorphoSys Announces Settlement in Patent Lawsuit with Janssen and Genmab
31 Jan 2019 //
BIOSPACE
Imbruvica® (Ibrutinib) : Janssen Biotech vs. Zydus, Cadila Healthcare
29 Jan 2019 //
PATENT LITIGATION
Prezista (darunavir) : Janssen Sc. Ireland vs. Amneal Pharma
20 Dec 2018 //
PATENT LITIGATION
Xarelto (rivaroxaban) : Bayer, Janssen Pharmaceuticals vs. Teva Pharmaceuticals
10 Dec 2018 //
PATENT LITIGATION
J&J unit to pay $360 million to U.S. to resolve charity kickback probe
07 Dec 2018 //
REUTERS
Xarelto (Rivaroxaban) : Bayer, Janssen vs. Teva
05 Dec 2018 //
PATENT LITIGATION
Cerdelga (eliglustat) : Genzyme vs. Cipla Ltd.
24 Nov 2018 //
PATENT LITIGATION
Celltrion clears final Inflectra patent hurdle
07 Aug 2018 //
KOREA BIOMED
NHS saved £324 million by switching to biosimilars and generics
02 Aug 2018 //
PHARMAPHORUM
Prezista® (Darunavir): Janssen Products v. Dr. Reddy`s Laboratories
24 May 2018 //
PATENT LITIGATION
FDA tries to shame drugmakers over tactics that delay generics
18 May 2018 //
FIERCE PHARMA
FDA ‘names and shames’ generic-blocking pharma companies
17 May 2018 //
PMLIVE
Invokana® (Canagliflozin) : Mitsubishi Tanabe Pharma v. Prinston Pharmaceutical
12 Apr 2018 //
PATENT LITIGATION
Zytiga® (Abiraterone Acetate): Btg International Limited v. MSN Pharmaceuticals
20 Feb 2018 //
PATENT LITIGATION
Imbruvica® (Ibrutinib): Pharmacyclics v. Cipla Limited
12 Feb 2018 //
PATENT LITIGATION
Opsumit (Macitentan): Actelion Pharmaceuticals v. Zydus Pharmaceuticals (USA)
31 Jan 2018 //
PATENT LITIGATION
Invega Sustenna® (Paliperidone):Janssen Pharmaceuticals V. Teva Pharmas Usa
17 Jan 2018 //
PATENT LITIGATION
Invokana® (Canagliflozin): Mitsubishi Tanabe Pharma Corporation v. Lupin
09 Jan 2018 //
PATENT LITIGATION
France fines J&J 25 million euros over painkiller patch
21 Dec 2017 //
REUTERS
Prezista® (Darunavir): Janssen Sciences Ireland Uc, V. Aurobindo Pharma
07 Sep 2017 //
PATENT LITIGATION
InvaGen Infringed Diabetes Drug Patent, Pharma Cos. Say
24 Aug 2017 //
LAW360
Invokana® (Canagliflozin): Mitsubishi Tanabe Pharma & Janssen , Cilag V. Sandoz Inc.
21 Jul 2017 //
PATENT LITIGATION
Xarelto® (Rivaroxaban): Bayer Intellectual Property Gmbh & Janssen Pharmaceuticals, Inc.,v. Mylan Pharmaceuticals
19 May 2017 //
PATENT LITIGATION
Xarelto® (rivaroxaban): Bayer Intellectual Property GMBH & Janssen V.Taro Pharma
21 Apr 2017 //
PATENT LITIGATION
Piramal Bulks up in Injectable Generics, Buying Five Drugs from J&J
12 Oct 2016 //
FIERCE PHARMA
J&J gets FDA approval for continuous manufacturing of Prezista
11 Apr 2016 //
FIERCE PHARMA MANUFACTURING
Lupin Launches Generic Ortho Tri-Cyclen® Lo Tablets in the US
06 Jan 2016 //
PR NEWS WIRE
Mylan Launches Generic Ortho Tri-Cyclen Lo® Tablets
05 Jan 2016 //
PR NEWS WIRE
Mylan announces U.S. launch of generic AXERT tablets
17 Nov 2015 //
NEWS MEDICAL
Mylan releases generic version of Invega in the U.S.
29 Sep 2015 //
NEWS MEDICAL
Allergan Launches Generic Version of INVEGA® (paliperidone)
26 Sep 2015 //
PR NEWS WIRE
J&J: Biosimilars will not replicate generic levels of competition or substitution
15 Sep 2015 //
BIOPHARMA-REPORTER
U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma
04 Sep 2015 //
PR NEWS WIRE
